Bioceres Crop Solutions Corp. (NASDAQ:BIOX – Get Free Report)’s share price traded up 4.8% on Monday . The company traded as high as $0.3989 and last traded at $0.3897. 283,297 shares changed hands during trading, a decline of 82% from the average session volume of 1,536,495 shares. The stock had previously closed at $0.3720.
Analysts Set New Price Targets
BIOX has been the topic of several analyst reports. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Bioceres Crop Solutions in a research report on Monday, December 29th. Canaccord Genuity Group dropped their price objective on shares of Bioceres Crop Solutions from $2.25 to $2.00 and set a “hold” rating on the stock in a report on Friday, January 2nd. One analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Bioceres Crop Solutions currently has an average rating of “Hold” and an average target price of $4.00.
Read Our Latest Stock Analysis on Bioceres Crop Solutions
Bioceres Crop Solutions Stock Up 1.8%
Bioceres Crop Solutions (NASDAQ:BIOX – Get Free Report) last issued its quarterly earnings results on Friday, March 13th. The company reported ($0.08) EPS for the quarter, missing analysts’ consensus estimates of $0.07 by ($0.15). The business had revenue of $73.67 million for the quarter, compared to analyst estimates of $104.55 million. Bioceres Crop Solutions had a negative net margin of 82.83% and a negative return on equity of 22.43%. Equities research analysts predict that Bioceres Crop Solutions Corp. will post -0.05 earnings per share for the current year.
Institutional Trading of Bioceres Crop Solutions
A number of hedge funds and other institutional investors have recently made changes to their positions in BIOX. Bank of America Corp DE boosted its holdings in shares of Bioceres Crop Solutions by 186.8% in the fourth quarter. Bank of America Corp DE now owns 5,735 shares of the company’s stock valued at $35,000 after acquiring an additional 3,735 shares in the last quarter. Jones Financial Companies Lllp lifted its position in Bioceres Crop Solutions by 3,535.8% in the first quarter. Jones Financial Companies Lllp now owns 5,490 shares of the company’s stock worth $25,000 after purchasing an additional 5,339 shares during the period. Ardsley Advisory Partners LP boosted its stake in Bioceres Crop Solutions by 4.7% during the 2nd quarter. Ardsley Advisory Partners LP now owns 993,614 shares of the company’s stock valued at $4,441,000 after purchasing an additional 45,000 shares in the last quarter. Jane Street Group LLC bought a new position in Bioceres Crop Solutions during the 2nd quarter valued at $202,000. Finally, PDT Partners LLC increased its position in shares of Bioceres Crop Solutions by 58.9% during the 2nd quarter. PDT Partners LLC now owns 28,180 shares of the company’s stock valued at $126,000 after purchasing an additional 10,449 shares during the period. 17.68% of the stock is currently owned by institutional investors.
Bioceres Crop Solutions Company Profile
Bioceres Crop Solutions Corp. is an agricultural biotechnology company focused on developing, manufacturing and commercializing a range of crop inputs designed to enhance yields and improve sustainability. The company’s portfolio includes biological seed treatments, inoculants for nitrogen fixation, specialty fertilizers and proprietary biopesticides, which are formulated to support plant health and resilience under varying environmental conditions.
Among its flagship offerings is the HB4 drought-tolerant wheat technology, the first genetically modified wheat developed to withstand water stress, which has received regulatory approval in several markets.
Further Reading
Receive News & Ratings for Bioceres Crop Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioceres Crop Solutions and related companies with MarketBeat.com's FREE daily email newsletter.
